Anlon Healthcare Debt & Borrowing: ₹27 Cr

Anlon Healthcare Investor Presentation: Key Takeaways

Q2FY27 consolidated revenue ₹105.6 Cr (+102.3% YoY), EBITDA ₹25.2 Cr (+84.1%), PAT ₹17.2 Cr (+84.4%). H1 FY27 revenue ₹193.2 Cr (+125.9%). Strategy: integrated API-to-formulations platform.

Anlon Healthcare Q2 FY27 Results: Net Profit ₹17.2 Cr, Up 84.9% YoY

Anlon Healthcare Ltd reported revenue from operations of ₹105.6 Cr (+102.3% YoY) and net profit of ₹17.2 Cr (+84.9% YoY) for Q2 FY27.

Key figure

Net profit ₹17.2 Cr · +84.9% YoY

Anlon Healthcare Preferential Issue

Anlon Healthcare received NSE and BSE in-principle approval for 8,05,35,651 preferential shares under a share swap. No cash consideration is stated.

Anlon Healthcare Board Meeting Date

Anlon Healthcare will hold a board meeting on 29 October 2026 to consider unaudited standalone and consolidated half-yearly results. The trading window is closed from 1 October to 31 October 2026.

Anlon Healthcare Other Announcement

Anlon Healthcare Limited filed the mandatory Regulation 74(5) certificate from its Registrar and Share Transfer Agent for the quarter ended September 30, 2026.

Anlon Healthcare Fund Raise of ₹250 Cr

Anlon Healthcare approved a preferential issue of convertible warrants for up to Rs. 250 Crore to raise funds for the company.

Value

₹250.0 Cr

Neogen Chemicals Debt & Borrowing: ₹500 Cr

Neogen Chemicals approved in-principle a Rs 500 Crore corporate guarantee for Neogen Morita's borrowings, subject to shareholder approval. The company reports no adverse impact.

Value

₹500.0 Cr

Satin Creditcare Network Debt & Borrowing: ₹1.83 Cr

Satin Creditcare paid Rs.1.83 Crore quarterly interest on its 10.40% April 2027 NCDs on 31 October 2026. The payment fulfils an existing debt obligation.

Value

₹1.83 Cr

AAA Technologies Debt & Borrowing: ₹6 Cr

AAA Technologies approved an inter-corporate loan of up to Rs.6 Crore to Transaction Solutions International at 12% interest. Repayable on demand; share-pledge security is proposed.

Value

₹6.00 Cr

Spandana Sphoorty Financial Debt & Borrowing: ₹12.5 Cr

Spandana Sphoorty partially redeemed Rs 12.50 Crore of its listed secured NCDs on 31 October 2026 by face-value redemption. Rs 200 Crore remains outstanding.

Value

₹12.50 Cr

Spandana Sphoorty Financial Debt & Borrowing: ₹2.71 Cr

Spandana Sphoorty paid monthly interest of Rs 2.71 Crore across two listed secured NCD series on 30 October 2026, on time. Series-wise amounts were Rs 2.01 Crore and Rs 0.70 Crore.

Value

₹2.71 Cr

Industrial Investment Trust Debt & Borrowing: ₹200 Cr

Industrial Investment Trust's board approved borrowing up to Rs. 200 Crore from banks, NBFCs and other lenders, within the Rs. 1,000 Crore shareholder limit. The enabling approval names no specific lender yet.

Value

₹200.0 Cr